Drug Profile
Tebanicline
Alternative Names: ABT 594; ABT-165594; ABT-166594.47Latest Information Update: 04 Feb 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer Abbott Laboratories; Merck & Co
- Class Azetidines; Non-opioid analgesics; Pyridines
- Mechanism of Action Cholinergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain; Pain